These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 37184409)
1. Identification of a Specific Biomarker of Acinetobacter baumannii Global Clone 1 by Machine Learning and PCR Related to Metabolic Fitness of ESKAPE Pathogens. Álvarez VE; Quiroga MP; Centrón D mSystems; 2023 Jun; 8(3):e0073422. PubMed ID: 37184409 [TBL] [Abstract][Full Text] [Related]
2. Accumulation of Antibiotic Resistance Genes in Carbapenem-Resistant Douraghi M; Kenyon JJ; Aris P; Asadian M; Ghourchian S; Hamidian M mSphere; 2020 Apr; 5(2):. PubMed ID: 32269158 [TBL] [Abstract][Full Text] [Related]
3. Acinetobacter baumannii NCIMB8209: a Rare Environmental Strain Displaying Extensive Insertion Sequence-Mediated Genome Remodeling Resulting in the Loss of Exposed Cell Structures and Defensive Mechanisms. Repizo GD; Espariz M; Seravalle JL; Díaz Miloslavich JI; Steimbrüch BA; Shuman HA; Viale AM mSphere; 2020 Jul; 5(4):. PubMed ID: 32727858 [No Abstract] [Full Text] [Related]
4. Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform. Renner LD; Zan J; Hu LI; Martinez M; Resto PJ; Siegel AC; Torres C; Hall SB; Slezak TR; Nguyen TH; Weibel DB Appl Environ Microbiol; 2017 Feb; 83(4):. PubMed ID: 27986722 [TBL] [Abstract][Full Text] [Related]
5. Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections. Qian Y; Zhou D; Li M; Zhao Y; Liu H; Yang L; Ying Z; Huang G Front Cell Infect Microbiol; 2023; 13():1223696. PubMed ID: 37662004 [TBL] [Abstract][Full Text] [Related]
7. Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19. Durán-Manuel EM; Cruz-Cruz C; Ibáñez-Cervantes G; Bravata-Alcantará JC; Sosa-Hernández O; Delgado-Balbuena L; León-García G; Cortés-Ortíz IA; Cureño-Díaz MA; Castro-Escarpulli G; Vélez-Reséndiz JM; Bello-López JM J Infect Dev Ctries; 2021 Jan; 15(1):58-68. PubMed ID: 33571146 [TBL] [Abstract][Full Text] [Related]
8. Crucial Role of the Accessory Genome in the Evolutionary Trajectory of Álvarez VE; Quiroga MP; Galán AV; Vilacoba E; Quiroga C; Ramírez MS; Centrón D Front Microbiol; 2020; 11():342. PubMed ID: 32256462 [No Abstract] [Full Text] [Related]
9. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital. Pandey R; Mishra SK; Shrestha A Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185 [TBL] [Abstract][Full Text] [Related]
10. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup. Tiwari V; Meena K; Tiwari M Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health. Denissen J; Reyneke B; Waso-Reyneke M; Havenga B; Barnard T; Khan S; Khan W Int J Hyg Environ Health; 2022 Jul; 244():114006. PubMed ID: 35841823 [TBL] [Abstract][Full Text] [Related]
12. Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development. Yu H; Xu Y; Imani S; Zhao Z; Ullah S; Wang Q ACS Infect Dis; 2024 Jul; 10(7):2336-2355. PubMed ID: 38866389 [TBL] [Abstract][Full Text] [Related]
13. [Investigation of the clonal relationship between nosocomial Acinetobacter baumannii isolates by Rep-PCR]. Gulbudak H; Aslan G; Tezcan S; Ersoz G; Ulger M; Otag F; Kuyucu N; Emekdas G Mikrobiyol Bul; 2014 Apr; 48(2):316-24. PubMed ID: 24819269 [TBL] [Abstract][Full Text] [Related]
14. A study on nosocomial pathogens in ICU with special reference to multiresistant Acinetobacter baumannii harbouring multiple plasmids. Patwardhan RB; Dhakephalkar PK; Niphadkar KB; Chopade BA Indian J Med Res; 2008 Aug; 128(2):178-87. PubMed ID: 19001682 [TBL] [Abstract][Full Text] [Related]
15. Fluorescence High-Throughput Screening for Inhibitors of TonB Action. Nairn BL; Eliasson OS; Hyder DR; Long NJ; Majumdar A; Chakravorty S; McDonald P; Roy A; Newton SM; Klebba PE J Bacteriol; 2017 May; 199(10):. PubMed ID: 28242720 [TBL] [Abstract][Full Text] [Related]
16. CRISPR-based subtyping to track the evolutionary history of a global clone of Acinetobacter baumannii. Karah N; Wai SN; Uhlin BE Infect Genet Evol; 2021 Jun; 90():104774. PubMed ID: 33618003 [TBL] [Abstract][Full Text] [Related]
17. A large conjugative Acinetobacter baumannii plasmid carrying the sul2 sulphonamide and strAB streptomycin resistance genes. Hamidian M; Ambrose SJ; Hall RM Plasmid; 2016; 87-88():43-50. PubMed ID: 27601280 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
19. Phylogenomics of two ST1 antibiotic-susceptible non-clinical Koong J; Johnson C; Rafei R; Hamze M; Myers GSA; Kenyon JJ; Lopatkin AJ; Hamidian M Microb Genom; 2021 Dec; 7(12):. PubMed ID: 34874246 [No Abstract] [Full Text] [Related]
20. A GC1 Acinetobacter baumannii isolate carrying AbaR3 and the aminoglycoside resistance transposon TnaphA6 in a conjugative plasmid. Hamidian M; Holt KE; Pickard D; Dougan G; Hall RM J Antimicrob Chemother; 2014 Apr; 69(4):955-8. PubMed ID: 24235096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]